The drug is composed of a humanised monoclonal antibody that binds to human CD19, internalising into the cell where enzymes release the PBD-based warhead.
Researchers recently demonstrated that platinum nanoparticles can be used to kill liver cancer cells with greater selectivity than existing cancer drugs.
The destruction of a single kind of insulin-producing cell in the pancreas can lead to diabetes — but a study suggests that other cells could be modified to take its place and help to control blood sugar levels.
The fashion industry is seeing the beginnings of a biotechnological revolution where living beings are being used to make clothing, resulting in improved and more sustainable materials.
The only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood cancers – will be available on the NHS in England and Wales to eligible adults who did not respond to two or more previous treatments with DLBCL, with funding from the Cancer Drugs Fund (CDF).
Under this newly announced relationship, Novozymes commits to supplying the enzymes required by Attis to convert its pulp into sugar at all of its planned biorefineries.
Japan has approved a stem-cell treatment for spinal-cord injuries. The event marks the first such therapy for this kind of injury to receive government approval for sale to patients.
Researchers have successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, which affects more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America.